North American Educational Forum on Lymphoma

Introductory Breakouts (choose one)

• Lymphoma Overview for Newly Diagnosed Patients and Caregivers –Jacob Soumerai, MD, Massachusetts General Hospital
• Lymphoma Survivorship – Priyanka Pophali, MD, University of Wisconsin
• Relapsed/Refractory – How to Cope When your Lymphoma Returns? – Jennifer Amengual, MD, Columbia University Medical Center

Healthy Ways to Interact with the Internet/Social Media

• Giselle Perez Lougee, PhD, Massachusetts General Hospital

LRF Overview and Welcome

What to Know About Clinical Trials

• Laurie Sehn, MD, British Columbia Cancer Agency

Update on COVID-19

• John Leonard, MD, Weill Cornell Medicine/New York Presbyterian

30 minute Q&A with both speakers

Move Around and Stretch!

Disease Specific Breakout Sessions – B-Cell Lymphomas (choose one)

• Burkitt Lymphoma – Adam Olszewski, MD, Lifespan Cancer Institute at Rhode Island Hospital
• Primary Central Nervous System Lymphoma – Lakshmi Nayak, MD, Dana-Farber Cancer Institute
• CLL/SLL – Danielle Brander, MD, Duke University
• Diffuse Large B-Cell Lymphoma and Other Aggressive B-Cell Lymphomas (Double and Triple Hit) – Narendranath Epperla, MD, MS, Ohio State University Comprehensive Cancer Center
• Splenic Marginal Zone Extranodal MALT and Nodal Marginal Zone Lymphoma - Tycel Philips, MD, University of Michigan
• Follicular Lymphoma – Kami Maddocks, MD, Ohio State University
• Hodgkin Lymphoma – Matthew Mei, MD, City of Hope
• Mantle Cell Lymphoma – Ann LaCasce, MD, Dana-Farber Cancer Institute
• Waldenstrom Macroglobulinemia – Shuo Ma, MD, Northwestern University
• LRF Staff Overview of T-Cell Resources

Patients and Physicians Panel Discussion – Ed Forum Chairs and LRF Ambassadors

Nutrition: Fuel Your Fight

• Hannah Manella, MS, RD, CSO, LDN. Rush University Medical Center

Disease Specific Breakout Sessions – T-Cell Lymphomas (choose one)

• Anaplastic Large Cell Lymphoma – Francine Foss, MD, Yale University
• Angioimmunoblastic T-Cell Lymphoma – Neha Mehta-Shah, MD, University of Washington in St. Louis
• Cutaneous T-Cell Lymphomas – Pamela Allen, MD, Emory University
• Peripheral T-Cell Lymphoma NOS – Pierluigi Porcu, MD, Jefferson University Hospitals
• Rare T-Cell Lymphomas – Adult T-Cell Leukemia/Lymphoma, Enteropathy-Type T-Cell
• Lymphoma, Hepatosplenic Gamma-Delta T-Cell Lymphoma and Nasal NK/T-Cell
• Lymphomas – Steve Horwitz, MD, Memorial Sloan Kettering
• LRF Staff Overview of B-Cell Resources

Mindfulness and Meditation

Special Lymphoma Breakout Topics (choose one)

• Advanced Diagnostic and Biomarker Testing for Lymphoma – Eric Hsi, MD, Wakeforest University
• Adolescent and Young Adult Lymphoma and Survivorship – Kara Kelly, MD, Roswell Park Comprehensive Cancer Center
• Imaging and Scans: Why do I need it? – Carrie Thompson, MD, Mayo Clinic
• Minimal Residual Disease (MRD) – Matthew Davids, MD, Dana-Farber Cancer Institute
• Oral Agents – Craig Portell, MD, University of Virginia
• What to do When Lymphoma Transforms and What that Means – Loretta Nastoupil, MD, MD Anderson Cancer Center

Living with Lymphoma Breakouts (choose one)

• Caregivers Support Group – Molly Williamson, LCSW, Mayo Clinic, Arizona
• Managing Treatment Side Effects - Chemotherapy and Transplant– Sharyn Kurtz, PA-C, Dana-Farber Cancer Institute
• Health Insurance and Employment – Avoiding Financial Toxicity and Hardships – Joanna Morales, Esq. Triage Cancer

Immunotherapy and CAR T Cell Therapy

• Alex Herrera, MD, City of Hope and Bruce Cheson, MD, Johns Hopkins

Relapsed/Refractory Breakouts (choose one)

• CLL/SLL –Jacqueline Barrientos, MD, Northwell Health
• DLBCL – Jennifer Crombie, MD, Dana-Farber Cancer Institute
• Hodgkin– Reid Merryman, MD, Dana-Farber Cancer Institute
• Follicular– Paolo Strati, MD, MD Anderson Cancer Center
• Mantle Cell Lymphoma – Jonathan Cohen, MD, Emory University

Closing Remarks